1. Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies

   • Alexander F. Haddad
   • Jacob S. Young
   • Manish K. Aghi

   Topic Review 03 January 2021 Pages: 1 - 13

   

2. Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases

   • Sarah A. Weiss
   • Christopher Zito
   • Lucia B. Jilaveanu

   Laboratory Investigation Open access 24 September 2020 Pages: 15 - 25

   

3. Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma

   • Linghao Bu
   • N. U. Farrukh Hameed
   • Shuai Wu

   Laboratory Investigation 24 January 2021 Pages: 27 - 36

   

4. 5-ALA kinetics in meningiomas: analysis of tumor fluorescence and PpIX metabolism in vitro and comparative analyses with high-grade gliomas

   • Eva Christine Bunk
   • Andrea Wagner
   • Benjamin Brokinkel

   Laboratory Investigation 03 January 2021 Pages: 37 - 46

   

5. Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid

   • Yutaka Fujioka
   • Nobuhiro Hata
   • Masahiro Mizoguchi

   Laboratory Investigation Open access 08 January 2021 Pages: 47 - 54

   

6. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence

   • Vidya P. Nimbalkar
   • Banavathy S. Kruthika
   • Vani Santosh

   Laboratory Investigation 03 January 2021 Pages: 55 - 65

   

7. Aggresomes predict poor outcomes and implicate proteostasis in the pathogenesis of pediatric choroid plexus tumors

   • Nada Amer
   • Hala Taha
   • Shahenda El-Naggar

   Laboratory Investigation Open access 26 January 2021 Pages: 67 - 78

   

8. Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome

   • Rodney E. Wegner
   • Stephen Abel
   • Jason Sheehan

   Clinical Study 11 January 2021 Pages: 79 - 87

   

9. Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review

   • Dennis Lee
   • Robert A. Riestenberg
   • Orin Bloch

   Clinical Study 03 January 2021 Pages: 89 - 98

   

10. Stroke rate after external fractionated radiotherapy for benign meningioma

    • Dimitri Vanmarcke
    • Johan Menten
    • Maarten Lambrecht

    Clinical Study 04 January 2021 Pages: 99 - 106

    

11. Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers

    • Mariko DeWire
    • Craig Erker
    • Maryam Fouladi

    Clinical Study 27 January 2021 Pages: 107 - 114

    

12. Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma

    • Edouard Samarut
    • Alexandre Lugat
    • Vincent Roualdes

    Clinical Study 03 January 2021 Pages: 115 - 123

    

13. Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases

    • Michael Zhang
    • Adrian J. Rodrigues
    • Gordon Li

    Clinical Study 07 January 2021 Pages: 125 - 134

    

14. Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database

    • Takahisa Mikami
    • Bobby Liaw
    • Suriya Jeyapalan

    Clinical Study 09 January 2021 Pages: 135 - 144

    

15. Resected WHO grade I meningioma and predictors of local control

    • Kamila Nowak-Choi
    • Joshua D. Palmer
    • Maria Werner-Wasik

    Clinical Study 09 January 2021 Pages: 145 - 151

    

16. Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma

    • Antonio Dono
    • Mark Amsbaugh
    • Yoshua Esquenazi

    Clinical Study 25 January 2021 Pages: 153 - 162

    

17. Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?

    • Anthony Patrizz
    • Antonio Dono
    • Yoshua Esquenazi

    Clinical Study 22 January 2021 Pages: 163 - 172

    

18. Local control and patterns of failure for “Radioresistant” spinal metastases following stereotactic body radiotherapy compared to a “Radiosensitive” reference

    • K. Liang Zeng
    • Arjun Sahgal
    • Hany Soliman

    Clinical Study 16 January 2021 Pages: 173 - 182

    

19. Stereotactic gamma knife radiosurgery for orbital cavernous hemangioma: clinical outcome and visual function protection

    • Hsien-Chung Chen
    • Chaur-Jong Hu
    • David Hung-Chi Pan

    Clinical Study 24 January 2021 Pages: 183 - 193

    

20. Surgery on giant meningiomas in very old patients entails frequent postoperative intracranial hemorrhages and atypical histopathology

    • Roel H.L. Haeren
    • Ilari Rautalin
    • Mika Niemelä

    Clinical Study Open access 21 January 2021 Pages: 195 - 204